| | english | español | français |
Go to record ID

  Home|Finding Information|Record details   Printer-friendly version

Information Resource
Record information and status
Record ID
42106
Status
Published
Date of creation
2007-09-02 12:51 UTC (UNEP-GEF/6584)
Date of last update
2012-05-02 15:59 UTC (dina.abdelhakim@cbd.int)
Date of publication
2012-05-07 13:19 UTC (andrew.bowers@cbd.int)

General Information
Title
Sustainability, benefit to the community and ethics in the assessment of genetically modified organisms
Author
The Norwegian Biotechnology Advisory Board
Organization(s) involved in the publication of this resource
P.O.Box 522 Sentrum,
NO-0105 Oslo,
NorwayInternet:
Norway
Language(s)
  • English
Publication date
2009-11-01
Subject
Summary, abstract or table of contents
The purpose of the Norwegian Gene Technology Act is "to ensure that the production and use of genetically modified organisms takes place in an ethically and socially justifiable way, in accordance with the principle of sustainable development and without detrimental effects on health and the environment." (Section 1, Purpose of the Act). In section 10 of the Act (Approval) it is stated that "...Deliberate release of genetically modified organisms may only be approved when there is no risk of detrimental effects on health or the environment. In deciding whether or not to grant the application, significant emphasis shall also be placed on whether the deliberate release represents a benefit to the community and a contribution to sustainable development...." The Norwegian Biotechnology Advisory Board has an important role in assessing whether a proposed deliberate release ("deliberate release" includes all activities using LMOs that does not take place in facilities approved for contained use) takes place in an ethically and socially justifiable way, in accordance with the principle of sustainable development, and if the deliberate release represents a benefit to the community. Sustainability, benefit to the community and ethics in the assessment of genetically modified organisms" is a discussion paper by the Board on how to implement the concepts of sections 1 and 10 of the in the Gene Technology Act in assessment of LMOs.

The discussion paper was revised in 2006 with the English version published in 2009. Links to both the original paper from 2003 and the second edition are provided below.
Thematic areas
  • Biosafety policy and regulation
  • Scientific and technical issues
    • Risk assessment
  • Socio-economic and trade issues
Background material to the “Guidance on risk assessment of living modified organisms”
Is this document is recommend as background material for the “Guidance on Risk Assessment of Living Modified Organisms”
Yes
Section(s) of the “Guidance on Risk Assessment of Living Modified Organisms” this background material is relevant
Additional Information
Type of resource
  • Report / Review / Fact sheet / Notes
Identifier
ISBN 978-82-91-68369-0 (2009 edition); ISBN 82-91683-21-2 (2003 edition)
Rights
Please contact The Norwegian Biotechnology Advisory Board (contact information above)
Format
2009 edition:
Adobe Acrobat Reader (20 pages)
PDF

2003 edition:
Adobe Acrobat Reader (21 pages)
PDF
Keywords and any other relevant information
LMO categories: All LMO categories
Access to the resource